5B2P image
Entry Detail
PDB ID:
5B2P
Title:
Crystal structure of Francisella novicida Cas9 in complex with sgRNA and target DNA (TGA PAM)
Biological Source:
PDB Version:
Deposition Date:
2016-02-01
Release Date:
2016-03-02
Method Details:
Experimental Method:
Resolution:
1.70 Å
R-Value Free:
0.20
R-Value Work:
0.18
R-Value Observed:
0.18
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:CRISPR-associated endonuclease Cas9
Mutations:N995A
Chain IDs:A
Chain Length:1632
Number of Molecules:1
Biological Source:Francisella tularensis subsp. novicida U112
Polymer Type:polydeoxyribonucleotide/polyribonucleotide hybrid
Description:Guide RNA
Chain IDs:B
Chain Length:94
Number of Molecules:1
Biological Source:synthetic construct
Polymer Type:polydeoxyribonucleotide
Description:Target DNA
Chain IDs:C
Chain Length:30
Number of Molecules:1
Biological Source:Francisella tularensis subsp. novicida
Polymer Type:polydeoxyribonucleotide
Description:DNA (5'-D(*TP*GP*AP*TP*AP*TP*CP*GP*G)-3')
Chain IDs:D
Chain Length:9
Number of Molecules:1
Biological Source:Francisella tularensis subsp. novicida
Primary Citation
Structure and Engineering of Francisella novicida Cas9
Cell 164 950 961 (2016)
PMID: 26875867 DOI: 10.1016/j.cell.2016.01.039

Abstact

The RNA-guided endonuclease Cas9 cleaves double-stranded DNA targets complementary to the guide RNA and has been applied to programmable genome editing. Cas9-mediated cleavage requires a protospacer adjacent motif (PAM) juxtaposed with the DNA target sequence, thus constricting the range of targetable sites. Here, we report the 1.7 Å resolution crystal structures of Cas9 from Francisella novicida (FnCas9), one of the largest Cas9 orthologs, in complex with a guide RNA and its PAM-containing DNA targets. A structural comparison of FnCas9 with other Cas9 orthologs revealed striking conserved and divergent features among distantly related CRISPR-Cas9 systems. We found that FnCas9 recognizes the 5'-NGG-3' PAM, and used the structural information to create a variant that can recognize the more relaxed 5'-YG-3' PAM. Furthermore, we demonstrated that the FnCas9-ribonucleoprotein complex can be microinjected into mouse zygotes to edit endogenous sites with the 5'-YG-3' PAM, thus expanding the target space of the CRISPR-Cas9 toolbox.

Legend

Protein

Chemical

Disease

Primary Citation of related structures